ROLE OF CYTOPLASMIC P27KIP1 IN CELL MOTILITY AND METASTASIS
细胞质 P27KIP1 在细胞运动和转移中的作用
基本信息
- 批准号:7420770
- 负责人:
- 金额:$ 0.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-20 至 2007-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Metastasic tumor growth is the principal event leading to death in patients with cancer, however, its molecular basis is presently poorly understood. Metastasic tumor cells generally migrate at a faster rate than normal cells or non-metastasic tumor cells. This observation leads to the hypothesis that increased cell motility (migration) is necessary for cells to become metastasic. Recently, a novel cytosolic-dependent role for the cyclin:CDK inhibitor p27KIP1 in cell motility was identified. It was shown that HGF signaling via the Met receptor resulted in the nuclear export of p27 KIP1 into the cytoplasm. This cytosolic localization was required for p27 KIP1 to induce cell motility and resulted in actin cytoskeletal rearrangements. These results suggest that deregulated signaling in tumor cells induce cytoplasmic import of p27. Our central hypothesis is that in the cytoplasm, p27 assembles into a complex involved in cytoskeletal remodeling and cell migration resulting in increased metastasis. The cytoplasmic relocalization and involvement of p27 in actin cytoskeletal rearrangement are evolutionarily reminiscent of alpha factor pheromone signaling in yeast. Far1p, the yeast cyclin:cdk inhibitor, mediates both a G1 cell cycle arrest in the nucleus and induction of shmoo formation in the cytoplasm that orients the actin cytoskeleton toward the opposite mating partner . In response to alpha factor, Far1p translocates from the nucleus to the cytoplasm and interacts with Cdc24p, a guanine nucleotide exchange factor for Cdc42p. Consistent with this functional analogy, mutation of a Far1p-like sequence motif present in the p27 scatter domain inactivates both cell migration and actin rearrangement, but preserves the cell cycle arrest functions of p27. Our objective is to identify the proteins complexes binding to p27 in the cytoplasm by TAP-tag purification and mass spectrometry analysis.
这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金,因此可能会出现在其他CRISE条目中。列出的机构是针对中心的,而不一定是针对调查员的机构。转移性肿瘤生长是导致癌症患者死亡的主要事件,然而,其分子基础目前尚不清楚。转移性肿瘤细胞通常比正常细胞或非转移性肿瘤细胞迁移速度更快。这一观察结果导致了一种假设,即细胞运动(迁移)的增加是细胞发生转移所必需的。最近,一个新的细胞周期蛋白依赖性作用:CDK抑制物p27KIP1在细胞运动中被发现。结果表明,HGF信号通过Met受体导致p27KIP1的核输出进入细胞质。这种胞浆定位是p27KIP1诱导细胞运动所必需的,并导致肌动蛋白细胞骨架重排。这些结果表明,肿瘤细胞中的信号失控诱导了p27的胞浆输入。我们的中心假设是,在细胞质中,p27组装成一个参与细胞骨架重塑和细胞迁移的复合体,导致转移增加。P27在细胞质中的重新定位和参与肌动蛋白细胞骨架重排,在进化上使人联想到酵母中的阿尔法因子信息素信号。酵母细胞周期蛋白:CDK抑制剂Far1p既介导了细胞核中G1期细胞周期的停滞,又诱导了细胞质中shmoo的形成,使肌动蛋白细胞骨架朝向相反的交配伙伴。作为对α因子的反应,Far1p从胞核移位到细胞质,并与CDc24p相互作用,CDc24p是一种与CDc42p的鸟核苷酸交换因子。与这一功能相似的是,存在于p27散发域的Far1p样序列基序的突变使细胞迁移和肌动蛋白重排失活,但保留了p27的细胞周期停滞功能。我们的目标是通过TAP-Tag纯化和质谱分析来鉴定细胞质中与p27结合的蛋白质复合体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN F DOWDY其他文献
STEVEN F DOWDY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN F DOWDY', 18)}}的其他基金
Precision Genetic RNAi Medicines to Treat Metastatic Triple-Negative Breast Cancer (TNBC)
治疗转移性三阴性乳腺癌 (TNBC) 的精准基因 RNAi 药物
- 批准号:
10573227 - 财政年份:2022
- 资助金额:
$ 0.29万 - 项目类别:
Precision Genetic RNAi Medicines to Treat Metastatic Triple-Negative Breast Cancer (TNBC)
治疗转移性三阴性乳腺癌 (TNBC) 的精准基因 RNAi 药物
- 批准号:
10361926 - 财政年份:2022
- 资助金额:
$ 0.29万 - 项目类别:
Development of Next-Generation Precision Medicine RNAi Therapeutics to Treat AML
开发治疗 AML 的下一代精准医学 RNAi 疗法
- 批准号:
10044943 - 财政年份:2020
- 资助金额:
$ 0.29万 - 项目类别:
Treating Adenovirus Conjunctivitis with Next-Gen siRNN RNAi Prodrugs
使用下一代 siRNN RNAi 前药治疗腺病毒结膜炎
- 批准号:
9228066 - 财政年份:2017
- 资助金额:
$ 0.29万 - 项目类别:
Novel Cell Cycle Therapeutic Targets in Pancreatic Cancer
胰腺癌的新细胞周期治疗靶点
- 批准号:
8511187 - 财政年份:2013
- 资助金额:
$ 0.29万 - 项目类别:
Novel Cell Cycle Therapeutic Targets in Pancreatic Cancer
胰腺癌的新细胞周期治疗靶点
- 批准号:
8616738 - 财政年份:2013
- 资助金额:
$ 0.29万 - 项目类别:
Transduction of Tumor Suppressor Proteins into Gliomas
将肿瘤抑制蛋白转导至神经胶质瘤
- 批准号:
6522938 - 财政年份:2001
- 资助金额:
$ 0.29万 - 项目类别:
Transduction of Tumor Suppressor Proteins into Gliomas
将肿瘤抑制蛋白转导至神经胶质瘤
- 批准号:
6613762 - 财政年份:2001
- 资助金额:
$ 0.29万 - 项目类别:
Transduction of Tumor Suppressor Proteins into Gliomas
将肿瘤抑制蛋白转导至神经胶质瘤
- 批准号:
6482108 - 财政年份:2001
- 资助金额:
$ 0.29万 - 项目类别:
相似海外基金
MRC TS Award: Regulation of neutrophil functions by cell cycle proteins
MRC TS 奖:细胞周期蛋白调节中性粒细胞功能
- 批准号:
MR/X023087/1 - 财政年份:2023
- 资助金额:
$ 0.29万 - 项目类别:
Fellowship
Cell cycle proteins as key regulators of cardiac chemosensitivity
细胞周期蛋白作为心脏化疗敏感性的关键调节因子
- 批准号:
10353398 - 财政年份:2021
- 资助金额:
$ 0.29万 - 项目类别:
Cell cycle proteins as key regulators of cardiac chemosensitivity
细胞周期蛋白作为心脏化疗敏感性的关键调节因子
- 批准号:
10558622 - 财政年份:2021
- 资助金额:
$ 0.29万 - 项目类别:
Regulation of neutrophil functions by cell cycle proteins
细胞周期蛋白对中性粒细胞功能的调节
- 批准号:
MR/R02149X/1 - 财政年份:2018
- 资助金额:
$ 0.29万 - 项目类别:
Fellowship
Role of Musashi in the regulation of cell cycle proteins
Musashi 在细胞周期蛋白调节中的作用
- 批准号:
DP120100224 - 财政年份:2012
- 资助金额:
$ 0.29万 - 项目类别:
Discovery Projects
Interaction between HIV-1 and cell cycle proteins
HIV-1 和细胞周期蛋白之间的相互作用
- 批准号:
6594793 - 财政年份:2002
- 资助金额:
$ 0.29万 - 项目类别:
REGULATION OF CELL CYCLE PROTEINS DURING ANGIOGENESIS
血管生成过程中细胞周期蛋白的调节
- 批准号:
6497933 - 财政年份:2002
- 资助金额:
$ 0.29万 - 项目类别:
Interaction between HIV-1 and cell cycle proteins
HIV-1 和细胞周期蛋白之间的相互作用
- 批准号:
6608078 - 财政年份:2002
- 资助金额:
$ 0.29万 - 项目类别:














{{item.name}}会员




